4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-24-000042
Chief Financial Officer returned 235 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Carter Robert Ross · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-20 | Returned to the company : show line 1 in the form | −235 | $0.14 | $32 | 31,759 | D |
Loading xslF345X05/wk-form4_1732231303.xml…